Wed, Sep 17, 2014, 2:58 AM EDT - U.S. Markets open in 6 hrs 32 mins

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

tasseyg 2 posts  |  Last Activity: Aug 26, 2014 12:55 PM Member since: Aug 14, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Time to lighten up....

    by chinesehamsters Aug 22, 2014 12:29 PM
    tasseyg tasseyg Aug 26, 2014 12:55 PM Flag

    I agree. The company has an impressive technology platform with enormous potential. If current management cannot make it happen, some pharma will buy it out. The buyout rate is increasing as big pharma becomes increasingly desperate for pipeline. If you can't wait for that, okay, bail.

  • Investors seem amazed at the strong move in biotech stocks. This is largely a case of a rising tide lifts all boats. Biotech is slowly coming to dominate new drug production. Large pharmaceutical companies are increasingly desperate to refurbish their drug pipelines, hence the steady pace of buyouts. Speculation as to who is next is lifting most biotech stocks. Further, biotech is now a growth industry. Noted analyst Byron Wien in a recent interview on CNBC restated the emerging theme that an aging population will need more good drugs and biotech will be the source. IMGN is a "platform" technology stock, which makes its long-run potential above average, even for such a strong group.

IMGN
11.14+0.15(+1.36%)Sep 16 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.